Sitryx Therapeutics
Oxford, United Kingdom
Principal Scientist at Sitryx Therapeutics (Oxford, UK). Drug discovery research scientist focused on immunometabolism and translational pharmacology for autoimmune disease. Interests include T-cell/myeloid biology, target validation, and biomarker strategy to accelerate early clinical translation. Presenting in T Cell Biology & Targets in Autoimmune & Inflammatory Disease, Poster 0991.
0991: MTHFD2 is a Novel Metabolic Target in Autoimmune Disease
Monday, October 27, 2025
10:30 AM - 12:30 PM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose
